Comparable stake leader
Nantahala Capital Management, LLC
SEC ownership of KIORA PHARMACEUTICALS INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001372514.
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
28/44
Latest evidence
01 Jul 2026
- Public ticker
- KPRX on Nasdaq, KPHMW on OTC
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Nantahala Capital Management, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
28 of 44
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Nantahala Capital Management, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
01 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001372514
- Issuer location
- Encinitas, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of KIORA PHARMACEUTICALS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
28/44
Latest evidence
01 Jul 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
16 rows are not safely comparable across share classes.
13D/G row: Nantahala Capital Management, LLC
Showing 1-8 of 44 holder rows.
Quick read
Nantahala Capital Management, LLC leads the comparable SEC ownership view at 10%.
28 of 44 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Nantahala Capital Management, LLC
10%
PERCEPTIVE ADVISORS LLC
10%
Alyeska Investment Group, L.P.
10%
ADAR1 Capital Management, LLC
9.9%
Rosalind Advisors, Inc.
9.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 44 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
|
10%
|
$1,293,619
491,889 shares
|
+$140,489 | 30 Jun 2026 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
10%
|
$1,163,434
442,387 shares
|
$0 | 06 Apr 2026 |
| Alyeska Investment Group, L.P. |
13D/G
|
10%
|
$852,483
394,668 shares
|
+$689,126 | 31 Mar 2026 |
| ADAR1 Capital Management, LLC |
13D/G
13F
ADAR1 Capital Management GP, LLC · Company
|
9.9%
|
$1,250,197
475,378 shares
|
+$289,812 | 30 Jun 2026 |
| Rosalind Advisors, Inc. |
13D/G
|
9.9%
|
—
464,676 shares
|
$0 | 31 Dec 2025 |
| Orin Hirschman |
13D/G
|
4.9%
|
$380,178
192,984 shares
|
-$123,265 | 31 Dec 2025 |
| Nantahala Capital Partners Limited Partnership |
13D/G
|
3.4%
|
$321,270
148,736 shares
|
-$88,493 | 31 Mar 2026 |
| GOLDMAN SACHS GROUP INC |
13D/G
THE GOLDMAN SACHS GROUP, INC.
|
0%
|
$429
130 shares
|
$0 | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to KIORA PHARMACEUTICALS INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
ARMISTICE CAPITAL, LLC
Net 12M change
$0
Latest report
01 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10%+ Owner | $3,006,550 | Mixed | 30 Jul 2021 | ||
| Stephen From | Executive Chairman, Director | $259,264 | Mixed | 05 Jan 2022 | ||
| Brian M. Strem | President and CEO, Director | $113,528 | Mixed | 01 Jul 2026 | ||
| Sarah Romano | Chief Financial Officer | $87,117 | Mixed | 10 Feb 2022 | ||
| Eric Joseph Daniels | Chief Development Officer | $62,529 | Mixed | 01 Apr 2026 | ||
| Michael P. Manzo | VP of Engineering | $58,898 | Mixed | 03 Aug 2021 | ||
| Brenda Mann | VP of Research & Development | $57,971 | Mixed | 02 Nov 2021 | ||
| Melissa Tosca | Cfo | $50,303 | Mixed | 01 Jul 2026 | ||
| Praveen Tyle | Director | $19,855 | Filing P/S | 10 Jun 2026 | ||
| Erin Parsons | Director | $16,885 | Mixed | 10 Jun 2026 | ||
| Aron Shapiro | Director | $10,800 | Filing P/S | 10 Jun 2026 | ||
| Lisa Walters-Hoffert | Director | $4,825 | Filing P/S | 10 Jun 2026 | ||
| Carmine N. Stengone | Director | $4,600 | Filing P/S | 10 Jun 2026 | ||
| Susan L. Drexler | Interim CFO | Mixed | 21 Apr 2022 | |||
| Kenneth L. Gayron | Director | Mixed | 29 Sep 2023 | |||
| David Hollander | Director | Mixed | 10 Jun 2026 | |||
| Paul G. Chaney | Director | Mixed | 03 Mar 2023 |
Recent insider transactions for KIORA PHARMACEUTICALS INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Melissa Tosca | KPRX | Common Stock | Tax liability | -3.38% | -911 | 26,064 | 01 Jul 2026 | Direct | ||
| Brian M. Strem | KPRX | Common Stock | Tax liability | -3.08% | -1,869 | 58,823 | 01 Jul 2026 | Direct | ||
| Carmine N. Stengone | KPRX | Stock Option (right to buy) | Award | 25,000 | 25,000 | 10 Jun 2026 | Direct | |||
| Aron Shapiro | KPRX | Stock Option (right to buy) | Award | 25,000 | 25,000 | 10 Jun 2026 | Direct | |||
| Erin Parsons | KPRX | Stock Option (right to buy) | Award | 25,000 | 25,000 | 10 Jun 2026 | Direct | |||
| David Hollander | KPRX | Stock Option (right to buy) | Award | 25,000 | 25,000 | 10 Jun 2026 | Direct | |||
| Lisa Walters-Hoffert | KPRX | Stock Option (right to buy) | Award | 25,000 | 25,000 | 10 Jun 2026 | Direct | |||
| Praveen Tyle | KPRX | Stock Option (right to buy) | Award | 40,000 | 40,000 | 10 Jun 2026 | Direct | |||
| Melissa Tosca | KPRX | Common Stock | Tax liability | -3.33% | -929 | 26,975 | 01 Apr 2026 | Direct | ||
| Eric Joseph Daniels | KPRX | Common Stock | Tax liability | -2.84% | -929 | 31,741 | 01 Apr 2026 | Direct | ||
| Brian M. Strem | KPRX | Common Stock | Tax liability | -3.04% | -1,906 | 60,692 | 01 Apr 2026 | Direct | ||
| Eric Joseph Daniels | KPRX | Common Stock | Award | 25% | 6,533 | 32,670 | 06 Mar 2026 | Direct | ||
| Eric Joseph Daniels | KPRX | Stock Option (right to buy) | Award | 13,067 | 13,067 | 06 Mar 2026 | Direct | |||
| Brian M. Strem | KPRX | Common Stock | Award | 36.5% | 16,733 | 62,598 | 06 Mar 2026 | Direct | ||
| Brian M. Strem | KPRX | Stock Option (right to buy) | Award | 33,467 | 33,467 | 06 Mar 2026 | Direct | |||
| Melissa Tosca | KPRX | Common Stock | Award | 30.6% | 6,533 | 27,904 | 06 Mar 2026 | Direct | ||
| Melissa Tosca | KPRX | Stock Option (right to buy) | Award | 13,067 | 13,067 | 06 Mar 2026 | Direct | |||
| Eric Joseph Daniels | KPRX | Common Stock | Tax liability | -0.9% | -238 | 26,137 | 03 Mar 2026 | Direct | ||
| Brian M. Strem | KPRX | Common Stock | Tax liability | -0.52% | -238 | 45,865 | 03 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.